Biotest
Skander Romdhane has over 18 years of experience in the field of quality management and drug safety. Currently serving as the Corporate Drug Safety Manager for Audits and Educational Compliance, as well as the Quality Assurance Head of Audits and Supplier at Biotest AG since September 2014, Skander brings extensive expertise in regulatory compliance and quality assurance processes. Prior experience includes a role as Head of Quality Management at Plasma Service Europe GmbH from December 2004 to September 2014. Skander holds a Diplom in general biology from Goethe University Frankfurt and a certification as an Industriekaufmann from Konrad Adenauer Berufsschule - Kriftel.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.